Vector Analytics Acceleration Center

Your resource for viral and non-viral vector characterization

The application of nanomedicine is increasing rapidly, particularly with the use of AAVs and lipid nanoparticles as delivery vectors for nucleic acid-based vaccines and gene therapies.

While these delivery vectors show great promise, they pose significant manufacturing and analytical challenges due to their structural complexity. Consequently, you need to apply a combination of fit-for-purpose, complementary analytical tools during product development and process & quality control. Wherever you are on your journey to develop drug delivery vectors, now is the time to accelerate.

Pick a topic to get started or keep scrolling to discover more.

Viral vector characterization

 

Recommended reading

 

Discover blogs, whitepapers, application notes and more, to help you find solutions to challenges to the viral vector characterization challenges you’re currently facing.

 

 

BLOG: Delving deeper into AAV attributes

Overcoming challenges, in design, processing, formulation and quality control with analytics.

 

Read the blog

App Note: Identifying critical quality attributes of rAAV samples

Rapid, accurate, and robust measurements of viral titer & full capsid content for AAV samples.

 

Download app note

Measuring viral titer

Measuring viral titer at different stages of the development and production with light scattering.

 

Download app note

 

Latest webinars

 

Our webinars address the real challenges being faced in the development and manufacturing of viral vectors – and show you how analytical technology can help you overcome them.

 

Finding fit-for-purpose analytics

Carina Rodenstein, Scientist at Leukocare AG, compares analytical techniques for assessing AAV stability.

 

Find out what she discovered

AAV Analysis: viral titer and capsid empty/full ratios

Learn how advanced multi-detector GPC/SEC can help extend characterization of AAV serotypes

 

Watch now

More on-demand webinars

Discover more webinars covering various aspects of viral vector characterization.

 

Visit the webinar hub

Non-viral vector characterization

 

 

Recommended reading

 

Discover blogs, whitepapers, application notes and more, to help you find solutions to challenges to the nanoparticle characterization challenges you’re currently facing.

 

BLOG: Delving deeper into AAV attributes

Dr. Maryam Hussain and Dr. Ragy Ragheb answer common formulation and characterization questions.

 

Read the blog

App Note: What can light scattering tell me about LNP samples?

Learn about dynamic and electrophoretic light scattering and discover how they are being used in lipid nanoparticle and liposome research.

 

Download app note

Case Study: Unlocking more lipid nanoparticle insights

Particle Works develops and manufactures engineered nanoparticle synthesis platforms for the pharmaceutical and biotech industries.

 

Read their story

 

Latest webinars

 

Our webinars address the real challenges being faced in the development and manufacturing of viral vectors – and show you how analytical technology can help you overcome them.

 

Top tips for characterizing lipid nanoparticles

The first part in a six-part “Vector Analytics Masterclass” series. Join us for a deep dive into the methodologies you need for success.

 

Watch now

Transform vaccine production

Professor Yvonne Perrie, from the University of Strathclyde, explores the role of formulation and scale-independent manufacture, using a range of nanoparticle systems.

 

Watch now

More on-demand webinars

Discover more webinars covering various aspects of lipid nanoparticle vector characterization.

 

Visit the webinar hub